Diana Hausman
2019 - Zymeworks
In 2019, Diana Hausman earned a total compensation of $1.4M as Chief Medical Officer at Zymeworks, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $192,525 |
|---|---|
| Option Awards | $758,019 |
| Salary | $432,640 |
| Other | $21,341 |
| Total | $1,404,525 |
Hausman received $758K in option awards, accounting for 54% of the total pay in 2019.
Hausman also received $192.5K in non-equity incentive plan, $432.6K in salary and $21.3K in other compensation.
Rankings
In 2019, Diana Hausman's compensation ranked 7,647th out of 13,971 executives tracked by ExecPay. In other words, Hausman earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,647 out of 13,971 | 45th |
Division Manufacturing | 2,980 out of 5,701 | 48th |
Major group Chemicals And Allied Products | 1,120 out of 2,200 | 49th |
Industry group Drugs | 954 out of 1,886 | 49th |
Industry Pharmaceutical Preparations | 707 out of 1,398 | 49th |
Source: SEC filing on March 23, 2020.
Hausman's colleagues
We found four more compensation records of executives who worked with Diana Hausman at Zymeworks in 2019.